A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% ...

A Phase IIb/III trial with infants entering their first respiratory syncytial virus (RSV) season met its primary endpoints.

A large new study says the RSV vaccine is 80% effective at preventing hospitalization in older adults due to complications from the illness, and works just as well at protecting them from death or ...

The figures are slightly better than this time last year, the health department said, but still far below the state’s initial ...

Connecticut officials said Friday that the state has had two deaths from the flu and 15 to 20 people still die of COVID-19 ...

The drug clesrovimab also helped reduce RSV associated hospitalizations by 84.2% compared to placebo, Merck said.

There has been a surge in cases of a deadly virus with more babies admitted to hospital, according to the UK Health Security ...

Millions of people are eligible for free flu, Covid and RSV vaccines, but record low uptake has doctors distressed ...

FDA's approval of Astellas' therapy for gastric cancer, and CVS Health's leadership shuffle as Karen Lynch steps down amid ...

Winter is approaching in the Northern Hemisphere and people are gearing up for what they are calling the "tripledemic". This ...

It’s also available to people who live in care homes or people who are pregnant. For the first time, the RSV vaccine has been ...

A Charlottesville community vaccine fair set for 10 a.m. to 2 p.m. Oct. 26 at Burley Middle School will offer adults and ...